Tuesday, 20 April 2021

Reuters Global Healthcare: Brazil in talks to buy 100 mln more Pfizer shots, official says

Brazil in talks to buy 100 mln more Pfizer shots, official says

Brazil is negotiating to buy a new tranche of 100 million doses of the Pfizer Inc (PFE.N) COVID-19 vaccine, Communications Minister Fabio Faria wrote on Twitter on Tuesday.

EXCLUSIVE UNICEF says AstraZeneca supply problems outside India resolved

Problems that have delayed AstraZeneca (AZN.L) supplies to the COVAX vaccine-sharing facility have been resolved, UNICEF told Reuters on Tuesday, saying it should receive 65 million doses by end-May from manufacturers outside India.

J&J to resume rollout of COVID-19 vaccine in Europe with safety warning

Johnson & Johnson (JNJ.N) said on Tuesday it will resume rolling out its COVID-19 vaccine in Europe after the region's medical regulator said the benefits of the shot outweigh the risk of very rare, potentially lethal blood clots.

J&J to cooperate in study of rare clots linked to COVID-19 vaccine, German scientist says

A German scientist studying extremely rare blood clots linked to AstraZeneca's (AZN.L) COVID-19 vaccine said on Tuesday Johnson & Johnson (JNJ.N) has agreed to work with him on the research after similar serious side effects emerged in recipients of its shot.

European Medicines Agency: More than 300 cases of rare blood clot events worldwide

The European Union's drug regulator said on Tuesday there had been more than 300 cases worldwide of rare blood clotting incidents combined with low platelet counts after use of COVID-19 vaccines.

Toronto area to close some workplaces amid COVID-19 surge

Canada's biggest city Toronto and neighboring Peel, both of which are in the midst of a third wave of COVID-19 infections, on Tuesday said they would order businesses to close if they had outbreaks involving five or more people, medical officials said.

Italy health ministry recommends J&J vaccine for over 60s

Italy's health ministry on Tuesday recommended that the Johnson & Johnson COVID-19 vaccine be used for people over the age of 60, after Europe's drugs regulator said the jab may be linked to blood clotting issues among younger people.

EU regulator backs J&J shot, finds possible link to clots

Europe's drug regulator has found a possible link between Johnson & Johnson's (JNJ.N) COVID-19 vaccine and rare blood clotting issues in adults who received doses in the United States, but backed its overall benefits against any risks.

Argentina produces Russia's Sputnik V vaccine in regional first

An Argentine firm has produced test batches of Russia's Sputnik V COVID-19 vaccine, the first in Latin America, with aims to scale up manufacturing of the drug by mid-year as the wider region grapples with a new surge in infections.

'Hands of love': warm latex gloves mimic human touch for COVID-19 patients in Brazil

The fight against COVID-19 is a lonely one with patients forced into isolation in intensive care wards, removed from family and friends.

Related Videos

New Delhi faces hospital beds shortage

Biden says vaccine plan on track despite J&J pause

FDA outlines blood clot symptoms after J&J pause